Li, W.; Wilson, G.C.; Bachmann, M.; Wang, J.; Mattarei, A.; Paradisi, C.; Edwards, M.J.; Szabo, I.; Gulbins, E.; Ahmad, S.A.;
et al. Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model. Cancers 2022, 14, 2618.
https://doi.org/10.3390/cancers14112618
AMA Style
Li W, Wilson GC, Bachmann M, Wang J, Mattarei A, Paradisi C, Edwards MJ, Szabo I, Gulbins E, Ahmad SA,
et al. Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model. Cancers. 2022; 14(11):2618.
https://doi.org/10.3390/cancers14112618
Chicago/Turabian Style
Li, Weiwei, Gregory C. Wilson, Magdalena Bachmann, Jiang Wang, Andrea Mattarei, Cristina Paradisi, Michael J. Edwards, Ildiko Szabo, Erich Gulbins, Syed A. Ahmad,
and et al. 2022. "Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model" Cancers 14, no. 11: 2618.
https://doi.org/10.3390/cancers14112618
APA Style
Li, W., Wilson, G. C., Bachmann, M., Wang, J., Mattarei, A., Paradisi, C., Edwards, M. J., Szabo, I., Gulbins, E., Ahmad, S. A., & Patel, S. H.
(2022). Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model. Cancers, 14(11), 2618.
https://doi.org/10.3390/cancers14112618
